LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Home・Akciju saraksts・CVS Health Corp.

CVS Health Corp.

Slēgts

SektorsVeselības aprūpe

90.45 3.56

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

89.61

Max

90.87

Galvenie mērījumi
By Trading Economics
Ienākumi	5.7B 2.9B
Pārdošana	2.8B 106B
P/E Sektora vidējais	59 49.8
Dividenžu ienesīgums	3.24
Peļņas marža	2.784
Darbinieki	219,000
EBITDA	4.9B 3.3B

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+10.88% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	3.24% 2.25%
Nākamie ieņēmumi	2026. g. 30. jūl.
Nākamais dividenžu datums	2026. g. 31. jūl.
Nākamais Ex dividenžu datums	2026. g. 21. jūl.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	8.9B 105B
Iepriekšējā atvēršanas cena	86.89
Iepriekšējā slēgšanas cena	90.45

Ziņu noskaņojums

By Acuity

26%

74%

1 / 347 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

65.92 / 68.28 Atbalsts un pretestība

CVS Health Corp. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 6. maijs 11:02 UTC

Peļņas

CVS Health Stock Jumps After Earnings. What's Encouraging Wall Street. -- Barrons.com

2026. g. 6. maijs 10:47 UTC

Peļņas

CVS Health Stock Jumps After Earnings. What's Encouraging Wall Street. -- Barrons.com

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Net $2.94B >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Front Store Same-Store Sales Up 1.2% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Sees FY Adj EPS $7.30-Adj EPS $7.50 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Health Services Segment Revenue Up 11.0% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Sees FY Net $8.03B-Net $8.29B >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Sees FY EPS $6.24-EPS $6.44 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q EPS $2.30 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Healthcare Benefits Segment Revenue Up 3.3% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Adj EPS $2.57 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Health Care Benefits Segment's 1Q Medical Benefit Ratio 84.6% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Updates 2026 Cash Flow From Operations Guidance to at Least $9.5B From at Least $9B >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Increasing Full-Year 2026 EPS, Adj EPS and Cash Flow From Operations Guidance to Reflect Increases in Health Care Benefits and Pharmacy & Consumer Wellness Segments >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Prescriptions Filled Rose 3.6% on 30-Day Equivalent Basis >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health: 1Q Adjusted EPS Rose Primarily Due to Improved Adjusted Operating Income in Health Care Benefits Segment >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health: Maintaining a Cautious View for Remainder of the Year in Light of Continued Elevated Cost Trends and Potential for Macro Headwinds >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Healthcare Benefits Segment Revenue Up 3.3% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health: 1Q Health Services Segment Rev Rose Primarily Driven by Pharmacy Drug Mix and Brand Inflation, Partially Offset by Continued Pharmacy Client Price Improvements >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health: 1Q Health Care Benefits Segment Rev Rose Primarily Driven by Increase in Govt Business, Partially Offset by Decline as Result of CO's Exit of Individual Exchange Business in 2026 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue Flat >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health: 1Q Adj. Operating Income $5.15B >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Same-Store Prescription Volume Rose 6.8% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue $31.99B >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Front Store Same-Store Sales Up 1.2% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Raises 2026 View To EPS $6.24-EPS $6.44 Vs Prior View $5.94-$6.14 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Pharmacy Same-Store Sales Up 3.1% >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health Raises 2026 View To Adj EPS $7.30-Adj EPS $7.50 Vs Prior View $7-$7.20 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q EPS $2.30 >CVS

2026. g. 6. maijs 10:30 UTC

Peļņas

CVS Health 1Q Adj EPS $2.57 >CVS

Salīdzinājums

Cenas izmaiņa

CVS Health Corp. Prognoze

Cenas mērķis

By TipRanks

10.88% augšup

Prognoze 12 mēnešiem

Vidējais 100.4 USD 10.88%

Augstākais 107 USD

Zemākais 92 USD

Pamatojoties uz 16 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CVS Health Corp. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

16 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 16 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam CVS Health Corp. — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

65.92 / 68.28Atbalsts un pretestība

All events are bullish.

Bullish events outweigh bearish events.

Noskaņojums

By Acuity

1 / 347 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.